T. Kim Le

524 total citations
24 papers, 289 citations indexed

About

T. Kim Le is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, T. Kim Le has authored 24 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in T. Kim Le's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). T. Kim Le is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). T. Kim Le collaborates with scholars based in United States, Australia and United Kingdom. T. Kim Le's co-authors include Beata Korytowsky, Yang Zhao, Leslie Montejano, Dennis C. Ang, Zhun Cao, E.Q. Wu, G. Saïd, Brigitta U. Monz, Myriam Rosilio and Dinh Phung and has published in prestigious journals such as Journal of Hepatology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

T. Kim Le

21 papers receiving 285 citations

Peers

Countries citing papers authored by T. Kim Le

Since Specialization

Citations

This map shows the geographic impact of T. Kim Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Kim Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Kim Le more than expected).

Fields of papers citing papers by T. Kim Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Kim Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Kim Le. The network helps show where T. Kim Le may publish in the future.

Co-authorship network of co-authors of T. Kim Le

This figure shows the co-authorship network connecting the top 25 collaborators of T. Kim Le. A scholar is included among the top collaborators of T. Kim Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Kim Le. T. Kim Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	O-190 Hormone-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomised clinical trial 2024 ·Human Reproduction ·Lan N. Vuong, Vu N A Ho, Hieu H. Pham, (unknown), Tho D. Pham, (unknown), T. Kim Le, (unknown), Trang T. Ly, Anh H. Le, (unknown), (unknown), Johan Smitz, Robert B. Gilchrist, Tuong M. Ho	1
2	Clinically meaningful categorisation of ICD-10-AM (Australian modification) 2024 ·Health Information Management Journal ·Graeme Duke, (unknown), John D. Santamaria, (unknown), Andrew Hamilton, (unknown), (unknown), Zhuoyang Li, T. Kim Le, (unknown)	0
3	Outcomes of dose‐escalated IMRT and ADT in Octogenarians with prostate cancer 2023 ·Journal of Medical Imaging and Radiation Oncology ·T. Kim Le, (unknown), Thomas P. Shakespeare	0
4	No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-Up 2023 ·Cureus ·(unknown), (unknown), (unknown), T. Kim Le, Thomas P. Shakespeare	0
5	Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study 2021 ·BMC Cancer ·Stéphane Dalle, Laurent Mortier, Pippa Corrie, Michal Lotem, Ruth Board, Ana Arance, Frank Meiß, Patrick Terheyden, Ralf Gutzmer, (unknown), (unknown), (unknown), T. Kim Le, Susan D. Mathias, (unknown), Jennifer Lord‐Bessen, Andriy Moshyk, Srividya Kotapati, Mark R. Middleton	12
6	A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC) 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), T. Kim Le, Eric Hau, Gerard G. Hanna, Harriet E. Gee, Shalini Vinod, (unknown), David A. Palma, (unknown), (unknown), Jackie Buck, Rebecca Lim	13
7	Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer 2019 ·Gastric Cancer ·Ian Chau, Dung T. Le, Patrick A. Ott, Beata Korytowsky, (unknown), T. Kim Le, Ying Zhang, Teresa Sánchez, Gregory A. Maglinte, (unknown), (unknown), Dhiren Patel, (unknown)	12
8	Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer 2019 ·Clinical Colorectal Cancer ·Dung T. Le, Patrick A. Ott, Beata Korytowsky, (unknown), T. Kim Le, Ying Zhang, Gregory A. Maglinte, (unknown), Dhiren Patel, (unknown), Ian Chau	22
9	Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non–Small Cell Lung Cancer After Platinum Chemotherapy 2019 ·Clinical Lung Cancer ·Lee S. Schwartzberg, Beata Korytowsky, John R. Penrod, Ying Zhang, T. Kim Le, Cory Batenchuk, Lee M. Krug	29
10	P1.12-21 Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients with Small Cell Lung Cancer (SCLC) 2018 ·Journal of Thoracic Oncology ·Lee S. Schwartzberg, Beata Korytowsky, J.R. Penrod, Yong Yuan, Ting Gu, T. Kim Le, (unknown), Giovanni Selvaggi	4
11	PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON 2018 ·Value in Health ·Shannon Cope, Evan Popoff, (unknown), Rachel Goldgrub, Jeroen P. Jansen, J.R. Penrod, (unknown), D. Ross Camidge, Beata Korytowsky, Ting Gu, (unknown), A. Juarez-Garcia, T. Kim Le, Yong Yuan	2
12	Establishing the need for immuno-oncology (IO) therapy (tx) in second-line (2L) small cell lung cancer (SCLC) 2018 ·Annals of Oncology ·Lee S. Schwartzberg, (unknown), Yong Yuan, Ting Gu, T. Kim Le, (unknown), Beata Korytowsky, Giovanni Selvaggi	1
13	Systemic Treatment Patterns With Advanced or Recurrent Non–small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study 2017 ·Clinical Therapeutics ·(unknown), (unknown), Shinji Takai, T. Kim Le, (unknown), (unknown), Shozo Matsuoka, Yuichiro Ohe	28
14	Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States 2015 ·Clinical Therapeutics ·T. Kim Le, Dendy Macaulay, Anupama Kalsekar, Yong Yuan, Rachael Sorg, (unknown), Eric Q. Wu	4
15	Treatment Patterns, Health Care Resource Utilization, and Costs in U.S. Patients Diagnosed with Chronic Hepatitis C Infection Who Received Telaprevir or Boceprevir 2015 ·Journal of Managed Care & Specialty Pharmacy ·T. Kim Le, Anupama Kalsekar, Dendy Macaulay, Yong Yuan, Rachael Sorg, (unknown), (unknown), Eric Q. Wu	5
16	Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients 2012 ·Journal of Medical Economics ·T. Kim Le, Katherine B. Winfree, Hongbo Yang, Maryna Marynchenko, Andrew P. Yu, (unknown), Eric Q. Wu	18
17	Healthcare Costs Associated with Osteoarthritis in US Patients 2012 ·Pain Practice ·T. Kim Le, Leslie Montejano, Zhun Cao, Yang Zhao, Dennis C. Ang	34
18	Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder 2011 ·Journal of Medical Economics ·T. Kim Le, Brad Curtis, Kristin Kahle‐Wrobleski, Joseph A. Johnston, (unknown), (unknown)	16
19	PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTS 2011 ·Value in Health ·T. Kim Le, Katherine B. Winfree, Hongyan Yang, Maryna Marynchenko, Andrew P. Yu, (unknown), Eric Q. Wu	1
20	Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France 2007 ·Current Medical Research and Opinion ·E.Q. Wu, (unknown), G. Saïd, T. Kim Le, Brigitta U. Monz, Myriam Rosilio, (unknown)	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact